ADVANCED OR METASTATIC MERKEL CELL CARCINOMA
Clinical trials for ADVANCED OR METASTATIC MERKEL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED OR METASTATIC MERKEL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for ADVANCED OR METASTATIC MERKEL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental tumor injection aims to supercharge immunotherapy in rare skin cancer
Disease control Recruiting nowThis study tests whether adding an experimental drug called IFx-Hu2.0 (injected directly into a tumor) to the standard immunotherapy pembrolizumab can improve outcomes for people with advanced or metastatic Merkel cell carcinoma. About 118 adults who have not received checkpoint …
Matched conditions: ADVANCED OR METASTATIC MERKEL CELL CARCINOMA
Phase: PHASE2, PHASE3 • Sponsor: TuHURA Biosciences, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
Experimental combo therapy targets Hard-to-Treat skin cancer
Disease control Recruiting nowThis early study tests a new cancer vaccine called IFx-Hu2.0 given together with the immunotherapy drug pembrolizumab (Keytruda) in 9 adults with advanced or metastatic Merkel cell carcinoma. The vaccine is injected directly into a tumor, and pembrolizumab is given through an IV.…
Matched conditions: ADVANCED OR METASTATIC MERKEL CELL CARCINOMA
Phase: PHASE1 • Sponsor: TuHURA Biosciences, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC